Identification of serum miR-1915-3p and miR-455-3p as biomarkers for breast cancer.
Breast cancer is one of the most malignant diseases in women worldwide. Serum microRNAs (miRNAs), with the characteristics of high sensitivity and specificity, have recently attracted more attentions to serve as potential biomarkers for tumor diseases. In this study, 194 breast cancer patients'...
Main Authors: | Jian Guo, Chen Liu, Wei Wang, Yan Liu, Huiwen He, Chong Chen, Rong Xiang, Yunping Luo |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2018-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC6062026?pdf=render |
Similar Items
-
MiR-497-5p, miR-195-5p and miR-455-3p function as tumor suppressors by targeting hTERT in melanoma A375 cells
by: Chai L, et al.
Published: (2018-05-01) -
Detection of increased serum miR-122-5p and miR-455-3p levels before the clinical diagnosis of liver cancer in people with type 2 diabetes
by: Heung Man Lee, et al.
Published: (2021-12-01) -
miR-16-5p, miR-103-3p, and miR-27b-3p as Early Peripheral Biomarkers of Fetal Growth Restriction
by: Salvatore Tagliaferri, et al.
Published: (2021-03-01) -
miR-223-3p and miR-24-3p as novel serum-based biomarkers for myotonic dystrophy type 1
by: Demetris Koutalianos, et al.
Published: (2021-12-01) -
Analysis of miR-9-5p, miR-124-3p, miR-21-5p, miR-138-5p, and miR-1-3p in Glioblastoma Cell Lines and Extracellular Vesicles
by: Alja Zottel, et al.
Published: (2020-11-01)